Viewing Study NCT04364620


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-16 @ 5:44 PM
Study NCT ID: NCT04364620
Status: COMPLETED
Last Update Posted: 2025-04-06
First Post: 2020-04-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)
Sponsor: Alethia Biotherapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC Stage IV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung cancer View
None Chemotherapy View